The expressions of SPARC, COL3A1, and RUNX2 were significantly enhanced in alveolar bone from patients with AP, accompanied by increases in SPP1 and BGLAP (Figure 7A). This evidence concerns the gene COL3A1 and alkaline phosphatase measurement.